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Abstract
Background: This study was conducted to evaluate the immunohistochemical (IHC) expression
of interleukin 8 (IL-8) in skin biopsies of inflammatory acne vulgaris (IAV) in an attempt to
understand the disease pathogenesis.
Materials and methods: A total of 58 biopsies, 29 from lesional IAV and 29 normal non lesional
sites were immunostained for IL-8. The intensity of staining was evaluated in the epidermis and
dermis and was scored as mild, moderate and severe. The expression was correlated with the
clinical grade, disease course and histological changes.
Results: IL-8 immunoreactivity was expressed in lesional IAV compared to non lesional skin
biopsies (p < 0.001). Increased expression was significantly associated with epidermal hyperplasia
and follicular hyperkeratosis (p < 0.001). In addition, the more pronounced IL-8 expression of the
dermal endothelial cells and neutophilic inflammatory infiltrate correlated with dermal angiogenesis
and the extent of dermal inflammatory response (p < 0.001). Moreover, increased dermal
immunoreactivity paralleled progressive course (p = 0.02) but not the duration of the disease.
Conclusion: We were able to demonstrate altered immunoreactivity of IL-8 in IAV compared to
normal skin. Targeted therapy to block IL-8 production may hold promise in limiting the
deleterious effects of IL-8-mediated inflammatory response and angiogenesis.
Background
Acne vulgaris is a chronic inflammatory disease of the
pilosebaceous units characterized by the formation of
comedones, erythrematous papules and pustules, less fre-
quently by nodules or pseudocyts [1]. It is a pleomorphic
disorder with multifactorial pathogenesis [2]. Acne has a
significant economic and social impact as well as a nega-
tive effect on self-image and outlook, especially during the
emotionally critical period of adolescence [3]. Propioni-
bacterium acnes (P. acnes), an anaerobic pathogen plays
an important role in the pathogenesis by triggering the
proinflammatory mediators [4,5] through activation of
Toll-like receptors 2 (TLR2) [6-8]. Among these media-
tors, IL-8 originally identified as neutrophil-activating
peptide-1 [9], along with P. acnes induce chemotactic fac-
tors that play a role in attracting neutrophils to the pilose-
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baceous unit (6, 7, 8). The production of IL-8 by P. acnes
is through activation of the NF-kappa B [10]. Gene array
expression profiling in acne lesions reveals marked upreg-
ulation of genes, including IL-8, involved in inflamma-
tion and matrix remodelling [11].
To our knowledge, no reports evaluated the IL-8 IHC
expression in skin biopsies of inflammatory acne. There-
fore, this study was conducted to assess this expression
and to correlate it with disease severity and histological
changes in an attempt to understand the disease patho-
genesis. The elucidation of this role may highlight the




This study is a case-control-study involving 58 skin speci-
mens divided into two groups. The first group involved 29
specimens from patients suffering from IAV and the sec-
ond one 29 from non lesional skin of same patient, used
as a control. Acne severity was graded as mild, moderate
and severe according to the American Academy of Derma-
tology Consensus statement on acne classification [12].
Four to five mm skin biopsies were taken from the papular
lesion after obtaining patients' consent. Patients were ≥ 15
years old untreated or their treatment was stopped for at
least two months before the biopsies, and without sys-
temic or other inflammatory skin diseases. Complete
medical history, family history of acne and previous treat-
ment received were assessed.
Biopsies and pathological examination
Biopsies were taken under local anaesthesia and were
immediately embedded in Tissue Tek OCT compound
(Miles Inc., Elkhart, Indiana, USA). Five μm thick cryostat
sections were cut from tissue blocks and placed on super
frosted slides. Sections were air dried for 3 hours. Slides
were wrapped back to back in aluminum foil and stored
frozen at -70°C until the time of staining. The rest of the
biopsy was fixed in 10% neutral buffered formalin and
processed to paraffin blocks. Haematoxylin and eosin
(H&E) stained sections were assessed to evaluate the his-
topathological changes. The extent of inflammatory cells
and dermal blood vessels were semi-quantitatively
assessed as mild, moderate and severe, compared to the
control group.
Immunohistochemistry
IL-8 utilized in the study is a mouse monoclonal IgG2b
antibody raised against a recombinant protein corre-
sponding to amino acids 40–99 mapping at the carboxy
terminus of IL-8 of human origin (Santa Cruz, sc 8427).
All incubations were done at room temperature.
Prior to staining, sections were brought to room tempera-
ture. Tissue sections were fixed in acetone for 10 minutes,
air dried and submerged in phosphate buffered saline
(PBS) bath for five minutes, before the start of staining.
Excess buffer was tapped off followed by the incubation
for 60 minutes with the primary antibody diluted at
1:100. Slides were washed twice with PBS for 5 minutes.
The Dakocytomation, LSAB 2 was used as detection kit.
Biotinylated secondary antibody was applied to the tissue
sections for 15 minutes. After washing with PBS, strepta-
vidin was applied for 15 minutes. Slides were washed with
PBS then incubated with diaminobenzidine (DAB) chro-
mogen for 10 minutes. Slides were rinsed with distilled
water, counterstained with Harris hematoxylin (Hx),
dehydrated and finally mounted. Negative controls were
slides stained by omission of the primary antibody.
Staining interpretation
Cytoplasmic staining was considered positive. The inten-
sity of staining was evaluated as 0) negative or absence of
positive cells, 1) faint or mild, 2) moderate and 3) strong
staining.
Statistical analysis
Categorical data were compared using Chi-square test and
statistical significance was considered at p value < 0.05.
Results
Sixty two percent of the patients were adolescents. Most of
patients were females (82.7%) and 79.3% had positive
family history of IAV. Almost half (51.7%) of the patients
had a disease duration less than 1 year. The exposure to
comedogenic agents was positive in 41.4% and history of
medications known to cause acne was seen in 34.5%. The
demographic characteristics of the patients are summa-
rized in table 1.
IHC expression of IL8 was homogenous and confined to
the cytoplasm of the cells. It was identified in all IAV
patients with variable expressions in the epidermis and
dermis ranging from mild to strong. In the epidermis, all
keratinocytes were stained. In the dermis the expression
was identified in the pilosebaceous units, inflammatory
cells and endothelial cells. In the control group only two
cases showed mild epidermal expression, while no stain-
ing was observed in the remaining cases (figure 1).
Strong association has been found between the extent of
epidermal hyperplasia and hyperkeratosis and the epider-
mal IHC expression of IL-8 (p < 0.001). In addition, the
dermal expression significantly paralleled the extent of
inflammatory infiltrate (p < 0.001). Moreover, strong
association has been found between the extent of dermal
expression and the dermal blood vessels (p < 0.001). Fur-
thermore, significant association has been identifiedDiagnostic Pathology 2007, 2:4 http://www.diagnosticpathology.org/content/2/1/4
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between increased dermal IL-8 IHC expression and the
progressive disease course (p = 0.02) but not with the
duration of the disease. Table 2 illustrates these associa-
tions.
Discussion
Excessive sebum production secondary to sebaceous
gland hyperplasia is the first abnormality to occur in IAV
[13]. Subsequent hyperkeratinization of the hair follicle
prevents normal shedding of the follicular keratinocytes,
obstructing the follicle forming an inapparent micro-
comedo. Lipids and cellular debris accumulate within the
blocked follicle [14]. This microenvironment encourages
colonization of P. acne, which provokes an immune
response through the production of numerous inflamma-
tory mediators. Inflammation is further enhanced by fol-
licular rupture and subsequent leakage of lipids, bacteria
and fatty acids into the dermis.
Data from this study points out to altered immunoreactiv-
ity of IL-8 in the lesional skin of acne patients. This was
highlighted by the increased expression in IAV skin biop-
sies compared to normal ones. Increased immunoreactiv-
ity was significantly associated with epidermal
hyperplasia, follicular hyperkeratosis. In addition, the
more pronounced IL-8 expression of the endothelial cells
and neutrophilic infiltrate correlated with the extent of
dermal inflammatory response and dermal angiogenesis.
This expression is concordant with previous studies show-
ing that IL-8 is released by a variety of cell types including
monocytes, macrophages, T lymphocytes, fibroblasts,
endothelial cells and keratinocytes in response to inflam-
matory stimulus [4,15,16]. Epidermal hyperplasia and
follicular hyperkeratosis secondary to IL-8 production
have been noted in psoriatic skin [17]. Early studies on IL-
8 point out to its inflammatory nature as a chemokine
that attracts and degranulates neutrophils [18,19]. This
degranulation release potential key regulators of cell sig-
nalling during inflammation such as serine proteases,
cathepsin G, leucocyte elastase and proteinase at sites of
inflammation, triggering IL-8 and subsequently activate
different IL-8 receptors [20].
Contrary to other studies [14,21], IL-8 was mildly
expressed in normal keratinocytes in non lesional biop-
sies in two cases while it was absent in the rest. This may
be related to the antibody clone used in the present study.
In fact, the pattern of staining was different depending on
the clone used in the study of Sticherling et al [15], where
suprabasal keratinocytes were staining with 52E8 and all
keratinocytes were reactive with 46E5. However, the mild
or lack of expression of IL-8 in normal keratinocytes in the
present work points to its role in mediating and participat-
ing to the inflammatory response in IAV cases.
It has been suggested that local changes in the peripheral
blood vessels at the dermal papilla or in the interfollicular
region may play a role in evolution of IAV because blood
vessels can deliver proinflammatory cytokines that modu-
lated a range of inflammatory and proliferative processes
[16]. IL-8 may be a potential endothelial cell growth and
survival factor, interacting through its receptors expressed
Table 1: Clinical characteristics of the study population.
Parameters Acne (n = 29)
Frequency %
Age group in years (p < 0.01) 15 – 20 18 62.1
21 – 25 7 24.1
26 – 30 3 10.3
> 30 1 3.4
Sex (p < 0.01) male 5 17.2
female 24 82.8
Family history (p < 0.01) yes 23 79.3
no 6 20.7
Duration of disease in years (NS) < 1 – 2 15 51.8
> 2 – 5 10 34.4
> 5 4 13.8
History of exposure to comedogenic agent (NS) yes 12 41.4
no 17 58.6
History of medications known to cause acne (NS) yes 10 34.5
no 19 65.5
Previous treatment (NS) local 8 27.6
systemic 4 13.8
combined 7 24.1
no 10 34.5Diagnostic Pathology 2007, 2:4 http://www.diagnosticpathology.org/content/2/1/4
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A) Mild staining of epidermal keratinocytes and lack of staining in dermal cells in non lesional skin biopsy. B) Strong cytoplasmic  staining of epidermal keratinocytes, dermal endothelial and inflammatory cells Figure 1
A) Mild staining of epidermal keratinocytes and lack of staining in dermal cells in non lesional skin biopsy. B) Strong cytoplasmic 
staining of epidermal keratinocytes, dermal endothelial and inflammatory cells. IL-8 IHC, DAB, Hx counterstaining × 40Diagnostic Pathology 2007, 2:4 http://www.diagnosticpathology.org/content/2/1/4
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by endothelial cells. The mechanism of IL-8 regulation of
angiogenesis may be in part due to enhanced proliferation
and survival of endothelial cells by differential expression
of antiapoptosis genes and in part by activation of matrix
metalloproteinases 2 and 9 [16]. This point is supported
in the present study by an increase in endothelial cells
IHC expression of IL-8 and increased dermal blood vessels
in the skin biopsies of IAV patients.
Conclusion
We were able to demonstrate the altered immunoreactiv-
ity of IL-8 in IAV compared to normal non lesional skin.
An important feature of this study is the strong association
between IL-8 IHC expression of endothelial cells and der-
mal inflammatory response and dermal angiogenesis. Tar-
geted therapy to block IL-8 production may hold promise
in limiting the deleterious effects of IL-8-mediated inflam-
matory response and angiogenesis.
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